Patient preferences of German and Swiss melanoma patients with regard to life-threatening side effects in the context of adjuvant immunotherapy - a qualitative GerMelaTox-A substudy

Peters W, Maul LV, Huning S, Hassel JC, Heinzerling L, Loquai C, Gutzmer R, Sachse MM, Blome C, Kah-Ler K (2022)

Publication Type: Conference contribution

Publication year: 2022

Journal

Journal der Deutschen Dermatologischen Gesellschaft Wiley-Blackwell

Publisher: WILEY

City/Town: HOBOKEN

Pages Range: 94-95

Conference Proceedings Title: JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT

Authors with CRIS profile

Lucie Heinzerling Department of Dermatology

Involved external institutions

Klinikum Dortmund DE Germany (DE) Universitätsspital Basel CH Switzerland (CH) Johannes Wesling Klinikum Minden DE Germany (DE) Universitätsmedizin der Johannes Gutenberg-Universität Mainz DE Germany (DE) Universitätsklinikum Hamburg-Eppendorf (UKE) DE Germany (DE) Universitätsklinikum Schleswig-Holstein (UKSH) DE Germany (DE) Klinikum Bremerhaven-Reinkenheide DE Germany (DE)

How to cite

APA:

Peters, W., Maul, L.V., Huning, S., Hassel, J.C., Heinzerling, L., Loquai, C.,... Kah-Ler, K. (2022). Patient preferences of German and Swiss melanoma patients with regard to life-threatening side effects in the context of adjuvant immunotherapy - a qualitative GerMelaTox-A substudy. In JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (pp. 94-95). HOBOKEN: WILEY.

MLA:

Peters, W., et al. "Patient preferences of German and Swiss melanoma patients with regard to life-threatening side effects in the context of adjuvant immunotherapy - a qualitative GerMelaTox-A substudy." Proceedings of the JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT HOBOKEN: WILEY, 2022. 94-95.

BibTeX: Download